Zavzpret for Migraine: How the Nasal Spray Works

Zavzpret is the brand name for zavegepant, a prescription nasal spray for treating migraine attacks with or without aura in adults. It is an acute treatment: its job is to help with an attack already happening, rather than prevent future attacks. [2]

For someone whose migraine includes vomiting, swallowing a tablet can be difficult. A nasal option may be worth discussing, but the route is only one part of the decision. Your medical history, previous treatment responses, other medicines, and the safety plan all matter.

How Zavzpret works

Zavegepant belongs to the gepant family. It blocks the receptor for calcitonin gene-related peptide, or CGRP, a chemical messenger involved in migraine. Zavzpret delivers that medicine through the nose. It is a different medicine class from triptans and from dihydroergotamine. [3]

The distinction helps organize a treatment discussion. “Migraine nasal spray” describes a delivery method, not a single drug. Two sprays can have different interactions and precautions. Likewise, the fact that some CGRP medicines are preventive treatments does not make Zavzpret a preventive treatment. Read medicines for attacks versus prevention for the broader distinction.

When a nasal treatment may be useful

International Headache Society recommendations include nonoral treatment options for people who vomit early during an attack. They also identify gepants as options when triptans are unsuitable or have not provided sufficient benefit. The choice still depends on the individual situation. [5]

A useful starting point is a specific problem: “I cannot keep a tablet down,” “pain improves but returns,” or “side effects stop me from using my prescription.” These describe different treatment needs. Bring the names of medicines you have tried, how you used them, and what happened afterward. A vague list of “failed medicines” can hide an important detail, such as a formulation you could not tolerate.

What the research can tell you

In a randomized phase 3 trial, about 24% of participants receiving zavegepant were pain free two hours after treatment, compared with about 15% receiving placebo. About 40% were free of their most bothersome associated symptom, compared with 31% with placebo. That symptom could be nausea or sensitivity to light or sound. [4]

Those results show benefit at the group level, and they also show that complete relief is not universal. Pain relief, pain freedom, and being able to function are separate outcomes. A person can improve without being entirely pain free.

The FDA's approval summary describes placebo-controlled trials, not a direct contest against every other migraine medicine. These studies do not establish that Zavzpret will be the best option for you or that it will work after a particular drug has not worked. [2]

Side effects and current safety warnings

Altered taste, nasal discomfort, and nausea were reported in the phase 3 trial. Record whether a side effect is brief, bothersome, or makes the medicine impractical for you. [4]

Current labeling also warns about new or worsening high blood pressure and Raynaud's phenomenon, which can cause painful, cold, numb, or color-changing fingers or toes. Report these changes promptly; stop Zavzpret if Raynaud's symptoms develop. Serious allergic reactions can occur. Breathing difficulty or facial, mouth, or throat swelling requires emergency help. A prior allergy to the product rules out its use. [1]

Zavzpret should be avoided with severe liver impairment or severe kidney impairment. Pregnancy and breastfeeding require an individualized discussion because available human data are limited. [1] Tell the clinician about these circumstances before a prescription decision.

Drug interactions include some nasal medicines

The label advises avoiding medicines that inhibit or induce OATP1B3 or NTCP transporters. Nasal decongestants can reduce absorption; avoid concurrent use. If unavoidable, the decongestant should be used at least one hour after Zavzpret. [1] A pharmacist can check the actual products on your list rather than expecting you to recognize transporter names.

Include nonprescription sprays, cold medicines, vitamins, supplements, and medicines taken only occasionally. Mention a new prescription even if it comes from another clinician. Keep a photo of each package when the name is hard to remember. Do not build a combination attack plan by adding a second medicine on your own.

A practical checklist before your visit

Ask for a written plan covering when to use the prescription, its limits, what to do if pain persists or returns, and when to contact the practice. Device instructions matter: the manufacturer provides a demonstration, and a pharmacist can review technique. Follow the instructions supplied with your own prescription. [6] Do not repeat Zavzpret within 24 hours; ask what to do if an attack continues. [3] The safety of treating more than eight migraines in 30 days has not been established. [1]

Frequently asked questions about Zavzpret

Can I use Zavzpret every day to prevent migraine?

No. It is approved for acute treatment, not prevention. [2] If attacks frequently interrupt your life, ask whether your overall plan should include prevention rather than relying only on an attack medicine.

Does a nontriptan medicine mean I can skip the safety review?

No. Different drug classes have different precautions. The blood pressure, circulation, allergy, organ function, and interaction review still matters. [1] Tell the clinician what made a previous medicine unsuitable so that the next decision addresses that problem.

What should I track after starting?

Record when you used it, pain and associated symptoms afterward, whether you returned to usual activities, any later return of pain, and side effects. Bring that record to follow-up. Describe both benefit and remaining difficulties so the next decision is based on your experience.

Discussing Zavzpret with TeleHeadache

TeleHeadache offers online assessment for eligible adults age 18 and older who are physically located in Florida and may prescribe migraine treatment when clinically appropriate. Clinical care can help review whether a nasal acute treatment fits your situation. Pharmacy medication costs are separate from clinical care costs; coverage and any prior authorization depend on your plan. A prescription or a particular medication is not guaranteed.

Official medication information and further reading

Official Zavzpret website · Zavzpret on Drugs.com · Drugs.com

Use the current U.S. prescribing information and your own prescription instructions when discussing this medicine with your clinician or pharmacist.

Educational information supports a discussion with your clinician and does not replace individualized medical evaluation. Medication choice and prescribing require clinical review.